Long-term clinical outcomes after sirolimus-eluting stent implantation

Trial Profile

Long-term clinical outcomes after sirolimus-eluting stent implantation

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 21 Oct 2015

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Oct 2015 New trial record
    • 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.
    • 02 Sep 2015 Stents were implanted between April 2004 and December 2006, and the median follow-up period was 8.2 years, according to the ESC 2015 abstract
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top